Mineralys Therapeutics Inc — Cash Flow (NASDAQ:MLYS) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -81.17 M-166.31 M-142.42 M -142.42 M Cash from investing activities -160.47 M114.96 M-389.75 M -389.75 M Cash from financing activities 203.25 M116.14 M591 M 591 M Free cash flow -81.17 M-166.41 M-142.43 M -142.43 M

Haberler

Mineralys Therapeutics MLYS: Tıbbi direktör 59 bin dolarlık hisse sattı

Mineralys Therapeutics, Jeffrey Munsie’yi hukuk direktörü atadı

Jefferies, ilaç endişeleri nedeniyle Mineralys hedefini düşürdü

Jefferies cuts Mineralys Therapeutics price target on drug concerns

Mineralys: Big Pharma Threatens To Undermine Likely Hypertension Drug Approval (MLYS)

Stifel, Mineralys hissesi için Al tavsiyesini yineledi

Stifel reiterates Buy rating on Mineralys stock, $52 target

BofA, Mineralys Therapeutics için hisse hedefini yükseltti

BofA raises Mineralys Therapeutics stock price target on NDA progress

Mineralys Therapeutics, Inc. (MLYS) Q4 2025 Earnings Call Transcript

FDA kararı yaklaşırken Mineralys kazançları odakta

Mineralys earnings in focus as FDA lorundrostat decision looms